金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301509 金凯生科

午间休市 12-16 11:30:00

{"stockData":{"symbol":"301509","market":"SZ","secType":"STK","nameCN":"金凯生科","latestPrice":32.4,"timestamp":1765860165000,"preClose":33.18,"halted":0,"volume":794980,"delay":0,"changeRate":-0.0235,"floatShares":56740900,"shares":120000000,"eps":0.8531,"marketStatus":"午间休市","change":-0.78,"latestTime":"12-16 11:30:00","open":33.16,"high":33.34,"low":32.35,"amount":26026400,"amplitude":0.0298,"askPrice":32.4,"askSize":117,"bidPrice":32.38,"bidSize":14,"shortable":0,"etf":0,"ttmEps":0.8531,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765861200000},"marketStatusCode":3,"adr":0,"adjPreClose":33.18,"symbolType":"stock","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":36.5,"lowLimit":29.86,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120446669,"isCdr":false,"pbRate":1.81,"roa":"--","peRate":37.979135,"roe":"4.74%","epsLYR":0.32,"committee":-0.412844,"marketValue":3902000000,"turnoverRate":0.014,"status":1,"floatMarketCap":1838000000},"requestUrl":"/m/hq/s/301509","defaultTab":"news","newsList":[{"id":"2591615351","title":"金凯生科：截至2025年12月10日股东数为14,355户","url":"https://stock-news.laohu8.com/highlight/detail?id=2591615351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591615351?lang=zh_cn&edition=full","pubTime":"2025-12-15 15:31","pubTimestamp":1765783860,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)12月15日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月10日股东人数是多少？金凯生科回复：尊敬的投资者，您好！截至2025年12月10日，公司股东数为14,355户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500012795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2588747788","title":"金凯生科：截至2025年11月28日股东数为14,539户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588747788?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:21","pubTimestamp":1764577272,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至11月30日的股东人数是多少？谢谢金凯生科回复：尊敬的投资者，您好！截至2025年11月28日，公司股东数为14,539户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100016265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2585970271","title":"金凯生科：截至2025年11月20日股东数为14,972户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585970271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585970271?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:48","pubTimestamp":1763711294,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，你好!请问截止至2025年11月20日，公司股东人数总数是多少?谢谢!金凯生科回复：尊敬的投资者，您好！截至2025年11月20日，公司股东数为14,972户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100018781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2585197786","title":"金凯生科：主要设备及材料均为国产","url":"https://stock-news.laohu8.com/highlight/detail?id=2585197786","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585197786?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:39","pubTimestamp":1763710749,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司在生产研发过程中，是否有关键材料或设备需要从日本进口？若两国关系突然紧张无法获得相关材料，是否会对贵司生产研发造成卡脖子风险？金凯生科回复：尊敬的投资者，您好！公司主要研发与生产设备及生产使用的主要原辅材料均为国产，不存在您提到的相关风险。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100018523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2584482129","title":"金凯生科最新公告：股东启鹭投资、青松投资、蓝区基金拟合计减持不超5.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2584482129","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584482129?lang=zh_cn&edition=full","pubTime":"2025-11-19 19:20","pubTimestamp":1763551247,"startTime":"0","endTime":"0","summary":"金凯生科公告称，股东启鹭投资计划减持不超过361.20万股，其中集中竞价减持不超过120.40万股，大宗交易减持不超过240.80万股；青松投资计划通过集中竞价减持不超过120.40万股；蓝区基金计划减持不超过233.91万股，其中集中竞价减持不超过120.40万股，大宗交易减持不超过113.51万股。减持原因均为自身资金需求。集中竞价减持期间为公告披露之日起十五个交易日后的三个月内，大宗交易减持期间为公告披露之日起三个交易日后的三个月内。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900033829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"1114057291","title":"金凯生科股东计划在三个月内减持最多5.9%的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1114057291","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114057291?lang=zh_cn&edition=full","pubTime":"2025-11-19 19:16","pubTimestamp":1763550987,"startTime":"0","endTime":"0","summary":"金凯生科表示，股东计划在未来三个月内减持最多5.9%的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2582311176","title":"金凯生科：截至2025年11月10日股东数为14,577户","url":"https://stock-news.laohu8.com/highlight/detail?id=2582311176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582311176?lang=zh_cn&edition=full","pubTime":"2025-11-12 08:54","pubTimestamp":1762908855,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止到11月10日，公司股东人数有多少？金凯生科回复：尊敬的投资者，您好！截至2025年11月10日，公司股东数为14,577户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200005858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2582813319","title":"股市必读：金凯生科（301509）11月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582813319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582813319?lang=zh_cn&edition=full","pubTime":"2025-11-10 02:44","pubTimestamp":1762713854,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，金凯生科报收于37.81元，下跌1.69%，换手率3.76%，成交量2.13万手，成交额8126.25万元。董秘最新回复投资者： 贵司产品能否用于生产戒烟药？公司目前产品不涉及相关领域。氟化氢是公司用于氟化生产的原料之一，公司本身不生产氟化氢。当日关注点来自交易信息汇总：11月7日主力资金净流出296.02万元，散户资金净流入300.12万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000001054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2581778890","title":"金凯生科：氟化氢是公司用于氟化生产的原料之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2581778890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581778890?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:36","pubTimestamp":1762504580,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)11月07日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，六氟磷酸锂主要的原材料包括氟化锂、五氯化磷、无水氟化氢、液氮。请问公司氟化工领域是否有氟化氢产品，谢谢。金凯生科回复：尊敬的投资者，您好！氟化氢是公司用于氟化生产的原料之一，公司本身不生产氟化氢。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700025710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2581105240","title":"金凯生科：芳香胺技术突破正评估应用潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2581105240","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581105240?lang=zh_cn&edition=full","pubTime":"2025-11-06 17:06","pubTimestamp":1762419968,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)11月06日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，最近芳香胺的技术突破，对公司的产品有什么成本利润方向的促进吗金凯生科回复：尊敬的投资者，您好！芳香胺是常用的有机合成中间体，公司已关注到相关技术并正在评估其应用潜力。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600026227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2580261497","title":"金凯生科：截至2025年10月31日股东数为14,677户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580261497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580261497?lang=zh_cn&edition=full","pubTime":"2025-11-03 15:51","pubTimestamp":1762156279,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止到10月31日，公司股东人数有多少？金凯生科回复：尊敬的投资者，您好！截至2025年10月31日，公司股东数为14,677户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300017076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2578366882","title":"股市必读：金凯生科(301509)股东户数1.38万户，较上期减少1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578366882","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578366882?lang=zh_cn&edition=full","pubTime":"2025-10-27 05:57","pubTimestamp":1761515832,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，金凯生科报收于36.45元，上涨2.24%，换手率3.42%，成交量1.94万手，成交额7029.99万元。来自股本股东变化：截至2025年10月20日，公司股东户数环比下降1.35%，户均持股上升至8740.0股，筹码集中度有所提升。股本股东变化股东户数变动近日金凯生科披露，截至2025年10月20日公司股东户数为1.38万户，较10月10日减少188.0户，减幅为1.35%。户均持股数量由上期的8622.0股增加至8740.0股，户均持股市值为31.74万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2578834386","title":"金凯生科（301509）2025年三季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2578834386","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578834386?lang=zh_cn&edition=full","pubTime":"2025-10-26 06:17","pubTimestamp":1761430634,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金凯生科发布2025年三季报。截至本报告期末，公司营业总收入4.88亿元，同比上升25.96%，归母净利润1.03亿元，同比上升163.24%。按单季度数据看，第三季度营业总收入1.39亿元，同比上升11.27%，第三季度归母净利润3166.87万元，同比上升339.92%。本报告期金凯生科应收账款上升，应收账款同比增幅达62.62%。去年的净利率为7.77%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600002348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509"],"gpt_icon":0},{"id":"2577374384","title":"金凯生科(301509)10月20日股东户数1.38万户，较上期减少1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577374384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577374384?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:16","pubTimestamp":1761210998,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2025年10月20日公司股东户数为1.38万户，较10月10日减少188.0户，减幅为1.35%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至10月20日，医疗服务行业平均股东户数为4.45万户。从股价来看，2025年10月10日至2025年10月20日，金凯生科区间跌幅为1.12%，在此期间股东户数减少188.0户，减幅为1.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300026491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2577384743","title":"金凯生科：截至2025年10月20日股东数为13,781户","url":"https://stock-news.laohu8.com/highlight/detail?id=2577384743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577384743?lang=zh_cn&edition=full","pubTime":"2025-10-22 08:54","pubTimestamp":1761094447,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)10月21日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止到10月20日收盘，公司股东人数有多少？金凯生科回复：尊敬的投资者，您好！截至2025年10月20日，公司股东数为13,781户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200006855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2575417917","title":"股市必读：金凯生科(301509)股东户数1.41万户，较上期减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575417917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575417917?lang=zh_cn&edition=full","pubTime":"2025-10-13 04:19","pubTimestamp":1760300351,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，金凯生科报收于36.72元，下跌0.49%，换手率3.07%，成交量1.74万手，成交额6411.37万元。股本股东变化股东户数变动截至2025年9月30日，金凯生科股东户数为1.41万户，较9月19日减少211.0户，减幅1.48%；户均持股数量升至8550.0股，户均持股市值为31.43万元。董秘最新回复投资者： 请问9月30日的股东户数是多少？截至2025年9月30日，公司股东数为14,088户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300001482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2574114335","title":"金凯生科：截至2025年9月30日股东数为14,088户","url":"https://stock-news.laohu8.com/highlight/detail?id=2574114335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574114335?lang=zh_cn&edition=full","pubTime":"2025-10-10 11:36","pubTimestamp":1760067385,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，你好!请问截止至2025年9月30日，公司股东人数总数是多少?谢谢!金凯生科回复：尊敬的投资者，您好！截至2025年9月30日，公司股东数为14,088户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000014335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2570089065","title":"股市必读：金凯生科(301509)股东户数1.43万户，较上期减少3.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570089065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570089065?lang=zh_cn&edition=full","pubTime":"2025-09-25 01:08","pubTimestamp":1758733700,"startTime":"0","endTime":"0","summary":"截至2025年9月24日收盘，金凯生科报收于36.17元，上涨1.46%，换手率3.77%，成交量2.14万手，成交额7706.76万元。当日关注点来自交易信息汇总：9月24日主力资金净流出439.93万元，散户资金净流入588.58万元。股本股东变化股东户数变动近日金凯生科披露，截至2025年9月19日公司股东户数为1.43万户，较9月10日减少541.0户，减幅为3.65%。户均持股数量由上期的8116.0股增加至8423.0股，户均持股市值为31.17万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500000549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2569549467","title":"金凯生科：截至2025年9月19日股东数为14,299户","url":"https://stock-news.laohu8.com/highlight/detail?id=2569549467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569549467?lang=zh_cn&edition=full","pubTime":"2025-09-23 08:58","pubTimestamp":1758589097,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止9月20日公司股东人数是多少？谢谢金凯生科回复：尊敬的投资者，您好！截至2025年9月19日，公司股东数为14,299户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300005882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2566595037","title":"金凯生科：截至2025年9月10日股东数为14,840户","url":"https://stock-news.laohu8.com/highlight/detail?id=2566595037","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566595037?lang=zh_cn&edition=full","pubTime":"2025-09-11 16:27","pubTimestamp":1757579237,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，请问9月10日的股东户数是多少个？金凯生科回复：尊敬的投资者，您好！截至2025年9月10日，公司股东数为14,840户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100026012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765860216811,"stockEarnings":[{"period":"1week","weight":-0.0192},{"period":"1month","weight":-0.1705},{"period":"3month","weight":-0.1503},{"period":"6month","weight":-0.0547},{"period":"1year","weight":0.1082},{"period":"ytd","weight":0.2958}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.0307},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.1414},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.154}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金凯(辽宁)生命科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14355人(较上一季度减少1.27%)","perCapita":"3952股","listingDate":"2023-08-03","address":"辽宁省阜新市阜新蒙古族自治县伊吗图镇氟化工园区安仁路6号","registeredCapital":"12044万元","survey":"　　金凯(辽宁)生命科技股份有限公司的主营业务是为全球原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。公司的主要产品是三氟甲氧基或三氟甲基的苯类中间体、氟代芳环类中间体、含氮杂环系列、氨的脂肪族有机衍生物、羧酸及其衍生物、烯烃类、非氟卤代苯类、酚类、酮类、异氰酸酯类。","listedPrice":56.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金凯生科,301509,金凯生科股票,金凯生科股票老虎,金凯生科股票老虎国际,金凯生科行情,金凯生科股票行情,金凯生科股价,金凯生科股市,金凯生科股票价格,金凯生科股票交易,金凯生科股票购买,金凯生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}